Biohacking
Oura Health Plans U.S. IPO to Raise Up to $3 Billion

Oura Health Plans U.S. IPO to Raise Up to $3 Billion

Theron Pulsewood

Edited by Theron Pulsewood

Fitness & Biohacking · Updated September 4, 2026

Oura Health, the maker of the popular smart ring, is preparing for a potential initial public offering (IPO) in the U.S. that could raise as much as $3 billion, valuing the company at over $16 billion. The company filed confidentially for the IPO in May and has engaged several major financial institutions as underwriters, including Goldman Sachs and JPMorgan Chase.

Share this story

0 people like this

Why it matters

  • ✓The IPO could provide Oura with additional capital to enhance its technology and product offerings, which may lead to improved health tracking for users.
  • ✓As Oura continues to innovate in the wearable health technology space, advancements may offer better insights into longevity and health optimization for consumers.
  • ✓Increased market presence and funding could lead to more competitive products in the health optimization sector, benefiting consumers.

Oura Health Plans U.S. IPO to Raise Up to $3 Billion

Oura Health, a leading innovator in the wearable technology space, is making headlines as it prepares for a potential initial public offering (IPO) in the United States. The company, known for its smart ring that tracks various health metrics, aims to raise up to $3 billion, which could elevate its valuation to over $16 billion.

Background on Oura Health

Founded in 2013, Oura Health has gained significant traction in the health and wellness sector with its smart ring, which provides users with insights into their sleep patterns, activity levels, and overall health. The device has become popular among health enthusiasts and biohackers seeking to optimize their well-being through data-driven insights. The company's focus on user-friendly design and comprehensive health tracking has positioned it as a leader in the wearable technology market.

Details of the IPO

Oura Health filed confidentially for its IPO in May 2023, a common practice that allows companies to gauge investor interest before making a public offering. The decision to go public comes at a time when the wearable technology market is expanding rapidly, driven by increasing consumer interest in health optimization and personal data tracking.

To facilitate the IPO, Oura has enlisted the help of several prominent financial institutions, including Goldman Sachs, Morgan Stanley, JPMorgan Chase, Allen & Co., and Jefferies. These underwriters are expected to assist in navigating the complexities of the public offering process and attracting potential investors.

Implications for Longevity and Health Optimization

The potential IPO of Oura Health is significant for several reasons, particularly for those interested in longevity and health optimization:

  1. Increased Funding for Innovation: The capital raised through the IPO could enable Oura to invest further in research and development. This could lead to advancements in their technology, resulting in more accurate health metrics and better user experiences. For health optimizers, this means access to improved tools for tracking and enhancing their well-being.

  2. Market Competition: As Oura solidifies its position in the market, it may encourage other companies to innovate and compete in the wearable health technology space. Increased competition can lead to better products and services for consumers, ultimately benefiting those who are focused on health optimization and longevity.

  3. Enhanced User Insights: With more resources, Oura may develop new features or improve existing ones, providing users with deeper insights into their health. This could empower individuals to make more informed decisions regarding their lifestyle choices, which is crucial for those pursuing longevity.

Conclusion

Oura Health's preparation for a U.S. IPO represents a significant milestone for the company and the wearable technology market. As the company seeks to raise up to $3 billion, the implications for longevity enthusiasts and health optimizers are promising. With potential advancements in technology and increased market competition, consumers may soon have access to even more sophisticated tools to help them achieve their health and longevity goals. As the IPO process unfolds, it will be interesting to see how Oura Health leverages this opportunity to further its mission of empowering individuals through health data.

OuraIPOwearable technologyhealth optimizationlongevity
Longevity Signal briefs are AI-assisted and human-reviewed. Content is informational, not medical advice. Sources are linked above. About our process.

Newsletter

Your weekly longevity signal. No spam.

Comments

Log in with

Loading comments…